Latest 8-K filings

CleanCore Solutions, Inc. announced the pricing of its public offering of common stock and warrants, aiming to raise approximately $100 million to fund AI infrastructure development.

Capstone Holding Corp. announced robust second-quarter 2026 results, featuring a 67% revenue surge and positive Stone Business Adjusted EBITDA, while reaffirming full-year guidance.

The Home Depot announced its CEO, Edward P. Decker, will take a temporary medical leave, with Ann-Marie Campbell and Richard V. McPhail stepping in to oversee operations.

Spruce Biosciences reported Q2 2026 results, highlighting progress towards a TA-ERT BLA submission in Q4 2026, initiation of the TrAnsform study, and a $5.5 million strategic investment from patient advocacy groups.

Adamas Trust, Inc. has entered into an underwriting agreement to sell $90 million in aggregate principal amount of 9.600% Senior Notes due 2031.

Rimini Street, Inc. has appointed Keith C. Costello as Executive Vice President and Chief Operating Officer, effective August 17, 2026, bringing extensive experience in scaling global operations and enterprise software.

Dyadic International announced its second-quarter 2026 financial results, highlighting progress in commercialization and partnerships, alongside an increased net loss and reduced cash reserves.

LiveOne announced record Q1 Fiscal 2027 results, with revenue reaching $19.4 million and Adjusted EBITDA at $4.3 million, marking a significant year-over-year improvement.

PodcastOne announced record first quarter fiscal 2027 revenue of $16.1 million and a 172% year-over-year increase in Adjusted EBITDA to $1.6 million.

Kartoon Studios has secured a streaming deal with Amazon Prime Video for its animated series 'Hundred Acre Wood,' set to launch February 18, 2027.

CID HoldCo, Inc. has received a notification from Nasdaq of its determination to delist the company's common stock due to failure to meet the minimum Market Value of Listed Securities requirement, though the company intends to appeal.

Splash Beverage Group, Inc. announced its intention to change its corporate name to Endovia Health Sciences, Inc., effective August 24, 2026, signaling a strategic shift into the cannabinoid health sciences sector.

Aprea Therapeutics reported Q2 2026 results, noting accelerated enrollment in its Phase 1 APR-1051 trial and early signs of clinical activity.

Beeline Holdings CEO Nicholas Liuzza has invested an additional $500,000 in the company, reinforcing confidence in its growth strategy and execution.

NeOnc Technologies announced positive topline results from the Phase 2a portion of its NEO100-01 study, showing a significant improvement in progression-free survival for patients with recurrent IDH1-mutant glioma.

Citius Oncology, Inc. has expanded its Board of Directors with the appointment of Jonathan Peri, Ph.D., J.D., an independent director with extensive experience in higher education, financial services, and corporate governance.

flyExclusive, Inc. announced robust financial results for Q2 2026, showcasing significant revenue growth, improved gross profit margins, and a positive shift to Adjusted EBITDA, alongside a strengthened balance sheet.

ENvue Medical, Inc. has entered into a $50 million committed equity facility with an institutional investor to provide flexible capital for working capital and preferred stock redemption.

Madrigal Pharmaceuticals announced the appointment of Dr. John C. Reed, a prominent biopharmaceutical research leader, to its Board of Directors, effective August 11, 2026.

Century Therapeutics reported Q2 2026 results, highlighting progress on CNTY-813 for Type 1 Diabetes with a pre-IND meeting with the FDA and strong preclinical data, alongside advancing CNTY-308 for autoimmune diseases, supported by a cash runway into Q1 2029.

Madison Square Garden Entertainment Corp. announced robust financial results for fiscal year 2026, with revenues up 13% to $1.1 billion and operating income up 16%.

Keurig Dr Pepper Inc. announced the appointment of Aaron Alt as an independent director to its Board, effective August 14, 2026, increasing the Board's size to ten members.

Avalyn Pharma announced second quarter 2026 financial results, highlighting the completion of enrollment for its MIST Phase 2b trial of AP01 and a cash runway projected into 2029.

Definium Therapeutics announced positive topline results from its Phase 3 Voyage study of DT120 ODT for generalized anxiety disorder, meeting primary and key secondary endpoints.

Brinker International announced robust fourth quarter and full year fiscal 2026 financial results, highlighting significant same-store sales growth for Chili's and providing optimistic guidance for fiscal year 2027.

Fusemachines Inc. announced a strategic agreement with Qintess, including a binding commitment for $6.5 million in AI product and service purchases over three years, with an equity component for long-term alignment.

Unicycive Therapeutics announced Q2 2026 financial results, reporting $61.4 million in cash and cash equivalents, and provided a business update indicating an expected New Drug Application resubmission for oxylanthanum carbonate (OLC) pending a successful third-party manufacturing vendor inspection.

Illumina, Inc. announced an offering of $300 million in 4.950% notes due 2029 to refinance existing debt maturing in September 2026.

Zapata Quantum and QuEra announce a strategic partnership to advance the commercial viability of quantum applications by combining QuEra's hardware roadmap with Zapata's application intelligence.

International Battery Metals Ltd. announced the appointment of Scott Colangelo to its Board of Directors, effective August 11, 2026.